The Philippines FDA is seeking comments from the stakeholders on the Draft Guidelines for the Recognition of Accredited Technical Service Providers for Radiation Dosimetry of Individual Monitoring Services. All comments shall be sent as “.doxc” or “.pdf” to cdrrhr.rrd@fda.gov.ph or comment sheet may be accessed here.
This guideline aims to recognize technical service providers for radiation dosimetry of individual monitoring services used in radiation facilities and activities within the mandate of the FDA, pursuant to DOH AO No. 2020-0035 and as part of FDA-CDRRHR’s authorization requirements for ionizing radiation facilities.
The highlighted key points are as follows:
- Only Philippine Accreditation Bureau of the Department of Trade and Industry (DTI-PAB) or International Laboratory Accreditation Cooperation’s Mutual Recognition Arrangement (ILAC-MRA) accredited Technical Service Providers (TSP) for ISO/IEC 17025, with scope of specific tests and measurements for Personal Dose Equivalent, shall be recognized by the FDA for radiation dosimetry of individual monitoring services, as part of the requirements for the authorization of an ionizing radiation facility under FDA CDRRHR.
- Radiation facilities shall check the following list of accredited providers under this circular:
- DTI-PAB Conformity Assessment Bodies, under Testing Laboratory
- ILAC-MRA
- Accreditation of laboratories that have expired shall be given a period of one (1) year from the date of expiration of accreditation to allow reaccreditation process or for transition and procurement of other accredited dosimetry laboratory services by the authorized radiation facility.
- A 1-year transition period is given to the authorized radiation facilities with existing arrangements for unrecognized Technical Service Providers to comply on this guideline.
For more in – depth information about this advisory, please click here.
If you have any queries about this announcement, please contact us at sales@andamanmed.com or click the button below.